ELTX
Elicio Therapeutics Inc.
1.90$
+4.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 62.4% | – | 69.0% | 59.1% | 59.3% | – | 38.1% | 14.9% | 2.5% | 13.8% | – | – | – | – | – | – | – | – | – | – | 26.2% | – | – | – | – | – | – | – | |
| 37.6% | – | 31.0% | 40.9% | 40.7% | – | 61.9% | 85.1% | 97.5% | 86.2% | – | – | – | – | – | – | – | – | – | – | -26.2% | – | – | – | – | – | – | – | |
| 1,498.4% | – | 1,671.2% | 734.5% | 2,408.1% | – | 2,670.6% | 908.1% | 25.6% | 706.0% | – | – | – | – | – | – | – | – | – | – | 911.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 4.2% | 96.6% | – | – | – | – | – | – | – | – | – | – | 237.3% | – | – | – | – | – | – | – | |
| 2,076.9% | – | 2,399.9% | 1,441.7% | 3,058.2% | – | 3,440.4% | 1,164.5% | 41.1% | 965.1% | – | – | – | – | – | – | – | – | – | – | 1,129.6% | – | – | – | – | – | – | – | |
| -2,039.2% | – | -2,368.9% | -1,400.8% | -3,017.4% | – | -3,378.5% | -1,079.3% | 56.4% | -878.9% | – | – | – | – | – | – | – | – | – | – | -1,155.7% | – | – | – | – | – | – | – | |
| – | – | 66.8% | 312.0% | 1,219.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.1% | – | – | – | – | – | – | – | |
| -2,301.0% | – | -2,790.3% | -2,136.5% | -6,290.8% | – | -3,161.5% | -1,075.6% | 57.4% | -864.1% | – | – | – | – | – | – | – | – | – | – | -1,201.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.1% | – | – | – | – | – | – | – | |
| -2,301.0% | – | -2,790.3% | -2,136.5% | -6,290.8% | – | -3,161.5% | -1,075.6% | 57.4% | -864.1% | – | – | – | – | – | – | – | – | – | – | -1,201.0% | – | – | – | – | – | – | – | |
| -2,281.6% | – | -2,700.1% | -1,807.5% | -5,039.2% | – | -3,123.3% | -1,064.5% | 58.3% | -850.2% | – | – | – | – | – | – | – | – | – | – | -1,154.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.